Alvotech And Teva : FDA Approves Selarsdi Injection For Psoriasis And Psoriatic Arthritis
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – The U.S. Food and Drug Administration has approved Selarsdi (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara, for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis in adults and pediatric patients 6 ye
